Proliferation method for hematopoietic stem cells of umbilical cord blood
A technology for hematopoietic stem cells and umbilical cord blood, applied in the field of cells, can solve the problems of bottlenecks in the formation ability and no breakthrough support, and achieve the effects of simple operation, increasing the total number of cells, and excellent CFU colony formation ability.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0040] Stemspan medium was purchased from STEMCELL company; cell protection agent was pure DMSO solution; umbilical cord blood was collected from healthy pregnant women and infants, and tested for hepatitis B, hepatitis C, syphilis, AIDS, cytomegalovirus, TORCH detection, mycoplasma, chlamydia , G-6PD and thalassemia were all negative. The transport conditions of the specimens from collection to transport back to the Guangdong Provincial Cord Blood Bank were kept at 4-8°C. Proceed with hematopoietic stem cell expansion as follows:
[0041] 1. Preparation of QS11 solution and cell expansion medium
[0042] QS11 (≥99%, GC), dissolved in the cell protection agent, prepared into a concentration of 10mmol / L QS11 storage solution;
[0043] Cell expansion medium: Add cytokine combination in Stemspan medium: IL-6 (concentration in cell expansion medium is 20ng / mL), IL-3 (concentration in cell expansion medium is 20ng / mL) mL), TPO (50 ng / mL in cell expansion medium), SCF (50 ng / mL i...
Embodiment 2
[0055] The specific experimental details of Example 2 are the same as those of Example 1 above, except that in the cell expansion medium containing QS11, the concentration of QS11 in the cell expansion medium is 0.5 μmol / L.
Embodiment 3
[0057] The specific experimental details of Example 3 are the same as those of Example 1 above, except that in the cell expansion medium containing QS11, the concentration of QS11 in the cell expansion medium is 1 μmol / L.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


